News Mirum Pharmaceuticals Receives the US FDA Approval for Ctexli to Treat Cerebrotendinous XanthomatosisByRidhi RastogiFebruary 24, 20250Comments
News Biocon Biologics Launches Yesintek (Biosimilar, Stelara) in the USByRidhi RastogiFebruary 24, 20250Comments
News Celltrion Secures the EC’s Approval for Avtozma (Biosimilar, RoActemra)ByRidhi RastogiFebruary 24, 20250Comments
News Celltrion Secures the EC’s Approval for Avtozma (Biosimilar, RoActemra)ByRidhi RastogiFebruary 24, 20250Comments
News Estrella Immunopharma Reports the Approval to Start a Higher Dose Cohort After the Completion of First Dose Cohort in STARLIGHT-1 StudyByRidhi RastogiFebruary 24, 20250Comments
News Alvotech and Teva Launch Selarsdi (Biosimilar, Stelara) in the USByRidhi RastogiFebruary 24, 20250Comments
VIEWPOINTS A Retrospective Analysis on Cardiac Amyloidosis: Mina Makar from AstraZeneca in an Illuminating Conversation with PharmaShotsBySaurabh ChaubeyFebruary 24, 20250Comments
News BMS’ Reblozyl Gains CHMP’s Positive Opinion to Treat Transfusion-Dependent Anemia Due to Myelodysplastic Syndrome (MDS) ByDipanshu DixitFebruary 23, 20250Comments
